Logo image of 5Q5.DE

SNOWFLAKE INC-CLASS A (5Q5.DE) Stock Fundamental Analysis

FRA:5Q5 - Deutsche Boerse Ag - US8334451098 - Common Stock - Currency: EUR

188.74  +2.78 (+1.49%)

Fundamental Rating

4

Taking everything into account, 5Q5 scores 4 out of 10 in our fundamental rating. 5Q5 was compared to 74 industry peers in the IT Services industry. The financial health of 5Q5 is average, but there are quite some concerns on its profitability. 5Q5 is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

5Q5 had positive earnings in the past year.
5Q5 had a positive operating cash flow in the past year.
5Q5 had negative earnings in each of the past 5 years.
5Q5 had a positive operating cash flow in 4 of the past 5 years.
5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCF5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

5Q5's Return On Assets of -17.15% is on the low side compared to the rest of the industry. 5Q5 is outperformed by 83.78% of its industry peers.
With a Return On Equity value of -58.09%, 5Q5 is not doing good in the industry: 82.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.15%
ROE -58.09%
ROIC N/A
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
5Q5.DE Yearly ROA, ROE, ROIC5Q5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

The Gross Margin of 5Q5 (66.58%) is comparable to the rest of the industry.
5Q5's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for 5Q5 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.5%
5Q5.DE Yearly Profit, Operating, Gross Margins5Q5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

5

2. Health

2.1 Basic Checks

5Q5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
5Q5 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, 5Q5 has more shares outstanding
5Q5 has a worse debt/assets ratio than last year.
5Q5.DE Yearly Shares Outstanding5Q5.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
5Q5.DE Yearly Total Debt VS Total Assets5Q5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

5Q5 has an Altman-Z score of 6.45. This indicates that 5Q5 is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 6.45, 5Q5 belongs to the best of the industry, outperforming 97.30% of the companies in the same industry.
5Q5 has a debt to FCF ratio of 3.09. This is a good value and a sign of high solvency as 5Q5 would need 3.09 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.09, 5Q5 is in line with its industry, outperforming 51.35% of the companies in the same industry.
A Debt/Equity ratio of 0.94 indicates that 5Q5 is somewhat dependend on debt financing.
5Q5's Debt to Equity ratio of 0.94 is on the low side compared to the rest of the industry. 5Q5 is outperformed by 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 3.09
Altman-Z 6.45
ROIC/WACCN/A
WACC9.54%
5Q5.DE Yearly LT Debt VS Equity VS FCF5Q5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.58 indicates that 5Q5 should not have too much problems paying its short term obligations.
The Current ratio of 5Q5 (1.58) is better than 72.97% of its industry peers.
A Quick Ratio of 1.58 indicates that 5Q5 should not have too much problems paying its short term obligations.
5Q5's Quick ratio of 1.58 is amongst the best of the industry. 5Q5 outperforms 81.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
5Q5.DE Yearly Current Assets VS Current Liabilites5Q5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

8

3. Growth

3.1 Past

5Q5 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -4.17%.
The Earnings Per Share has been growing by 334.45% on average over the past years. This is a very strong growth
5Q5 shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.50%.
5Q5 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 68.79% yearly.
EPS 1Y (TTM)-4.17%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%71.43%
Revenue 1Y (TTM)27.5%
Revenue growth 3Y43.81%
Revenue growth 5Y68.79%
Sales Q2Q%25.75%

3.2 Future

The Earnings Per Share is expected to grow by 40.26% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 22.97% on average over the next years. This is a very strong growth
EPS Next Y35.75%
EPS Next 2Y38.91%
EPS Next 3Y40.92%
EPS Next 5Y40.26%
Revenue Next Year25.85%
Revenue Next 2Y24.32%
Revenue Next 3Y24.04%
Revenue Next 5Y22.97%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
5Q5.DE Yearly Revenue VS Estimates5Q5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
5Q5.DE Yearly EPS VS Estimates5Q5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 4 6 8 10

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 241.97, 5Q5 can be considered very expensive at the moment.
Based on the Price/Earnings ratio, 5Q5 is valued a bit more expensive than the industry average as 70.27% of the companies are valued more cheaply.
5Q5's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.29.
A Price/Forward Earnings ratio of 139.89 indicates a quite expensive valuation of 5Q5.
67.57% of the companies in the same industry are cheaper than 5Q5, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.74, 5Q5 is valued quite expensively.
Industry RankSector Rank
PE 241.97
Fwd PE 139.89
5Q5.DE Price Earnings VS Forward Price Earnings5Q5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of 5Q5 indicates a slightly more expensive valuation: 5Q5 is more expensive than 70.27% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 100.36
EV/EBITDA N/A
5Q5.DE Per share data5Q5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 5Q5 does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as 5Q5's earnings are expected to grow with 40.92% in the coming years.
PEG (NY)6.77
PEG (5Y)N/A
EPS Next 2Y38.91%
EPS Next 3Y40.92%

0

5. Dividend

5.1 Amount

5Q5 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SNOWFLAKE INC-CLASS A

FRA:5Q5 (7/7/2025, 7:00:00 PM)

188.74

+2.78 (+1.49%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)05-21 2025-05-21/amc
Earnings (Next)08-19 2025-08-19/amc
Inst Owners67.07%
Inst Owner ChangeN/A
Ins Owners2.72%
Ins Owner ChangeN/A
Market Cap62.97B
Analysts80.71
Price Target202.07 (7.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)39.55%
Min EPS beat(2)10.37%
Max EPS beat(2)68.73%
EPS beat(4)4
Avg EPS beat(4)29.8%
Min EPS beat(4)10.37%
Max EPS beat(4)68.73%
EPS beat(8)7
Avg EPS beat(8)43.89%
EPS beat(12)10
Avg EPS beat(12)37.76%
EPS beat(16)14
Avg EPS beat(16)123.76%
Revenue beat(2)2
Avg Revenue beat(2)1.33%
Min Revenue beat(2)1.2%
Max Revenue beat(2)1.47%
Revenue beat(4)4
Avg Revenue beat(4)1.42%
Min Revenue beat(4)0.06%
Max Revenue beat(4)2.97%
Revenue beat(8)7
Avg Revenue beat(8)1.23%
Revenue beat(12)11
Avg Revenue beat(12)1.36%
Revenue beat(16)15
Avg Revenue beat(16)1.81%
PT rev (1m)9.11%
PT rev (3m)0.63%
EPS NQ rev (1m)0.39%
EPS NQ rev (3m)4.2%
EPS NY rev (1m)-4.54%
EPS NY rev (3m)-2.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.74%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)1.12%
Valuation
Industry RankSector Rank
PE 241.97
Fwd PE 139.89
P/S 19.23
P/FCF 100.36
P/OCF 88.7
P/B 30.67
P/tB 67.3
EV/EBITDA N/A
EPS(TTM)0.78
EY0.41%
EPS(NY)1.35
Fwd EY0.71%
FCF(TTM)1.88
FCFY1%
OCF(TTM)2.13
OCFY1.13%
SpS9.81
BVpS6.15
TBVpS2.8
PEG (NY)6.77
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.15%
ROE -58.09%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.58%
FCFM 19.17%
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.5%
F-Score4
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 3.09
Debt/EBITDA N/A
Cap/Depr 50.65%
Cap/Sales 2.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 6.45
F-Score4
WACC9.54%
ROIC/WACCN/A
Cap/Depr(3y)67.2%
Cap/Depr(5y)189.29%
Cap/Sales(3y)2.66%
Cap/Sales(5y)4.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.17%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%71.43%
EPS Next Y35.75%
EPS Next 2Y38.91%
EPS Next 3Y40.92%
EPS Next 5Y40.26%
Revenue 1Y (TTM)27.5%
Revenue growth 3Y43.81%
Revenue growth 5Y68.79%
Sales Q2Q%25.75%
Revenue Next Year25.85%
Revenue Next 2Y24.32%
Revenue Next 3Y24.04%
Revenue Next 5Y22.97%
EBIT growth 1Y-22.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.26%
EBIT Next 3Y82.3%
EBIT Next 5Y79.48%
FCF growth 1Y21.33%
FCF growth 3Y149.53%
FCF growth 5YN/A
OCF growth 1Y26.07%
OCF growth 3Y105.74%
OCF growth 5YN/A